PTEN loss and KRAS activation cooperate in murine biliary tract malignancies

Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes

(2012) Mina Komuta et al.   HEPATOLOGY

Either Kras activation or Pten loss similarly enhance the dominant-stable CTNNB1-induced genetic program to promote granulosa cell tumor development in the ovary and testis

(2011) J S Richards et al.   ONCOGENE

Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo

(2011) L K Mullany et al.   ONCOGENE

Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas

(2010) Ymera Pignochino et al.   BMC CANCER

High incidence of ras gene mutation in intrahepatic cholangiocarcinoma

(2010) Minoru Tada et al.   CANCER

Pten Inactivation Accelerates Oncogenic K-ras-Initiated Tumorigenesis in a Mouse Model of Lung Cancer

(2008) K. Iwanaga et al.   CANCER RESEARCH

Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin

(2008) Mina Komuta et al.   HEPATOLOGY